The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Share News (ABC)

  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Broker tips: Ocado, Abcam

Tue, 20th Jun 2023 08:22

(Sharecast News) - Online supermarket Ocado was under the cosh on Tuesday after JPMorgan Cazenove cut its price target on the shares to 400p from 450p and placed the stock on 'negative catalyst watch' into first-half results.

JPM said: "We believe Ocado's online grocery activities will continue to face meaningful headwinds in the next months."

The bank, which rates Ocado at 'underweight', said the latest Kantar data suggest ongoing market share gains for offline discounters given the current macro backdrop/falling consumer budgets.

It also noted that higher, inflation-driven average selling prices are almost fully offset by lower basket sizes, while cost inflation - wages but also electricity, icing etc - is negatively impacting UK Retail's bottom line.

JPM said it sees downside to consensus FY23 estimates.

"With Ocado's UK Retail operations barely profitable in 2023, we see limited scope for Retail to act as the required showcase for the company's Solutions operation," it said.

It also said it's "becoming clearer" that the shift towards more customer fulfilment centres (CFCs) is likely to remain slow for supermarkets as in-store picking solutions seem currently to be the preferred choice to better monetise the established branch network and limit capex.

JPM said that despite Ocado's recent share price weakness - the shares are down 30% year-to-date and 44% in the last 12 months - the current share price levels still reflect an additional 54 CFCs to be announced.

"With (a lack of) new partnership announcements likely to remain the key share price driver from here, we see risk-reward still as unattractive versus other names in the EU Internet sector and remain UW."

RBC Capital Markets downgraded Abcam to 'sector perform' from 'outperform' and cut the price target to $22 from $23 as it recommended investors take profit on bid anticipation.

It noted that the shares are up 40% in the last 10 days, and 65% in the quarter to date.

"It is unclear how advanced the 'strategic inquiries' are, and the valuation work in this report implies relatively little further upside on a transaction anyway," RBC said.

"We have always liked Abcam's fundamentals but see activist investor engagement and anticipation of a potential bid as likely to drive material volatility in the shares.

"While our $22 price target informs our downgrade to sector perform, we would take profits here."

More News
25 Jul 2016 15:15

Abcam describes 'another successful year' ahead of results

(ShareCast News) - Life science research tools supplier Abcam posted a trading update for the year to 30 June on Monday, ahead of the publication of its financial results, due 12 September. The AIM-traded firm described "another successful year" and claimed to have achieved above market revenue grow

Read more
20 Jun 2016 15:35

Abcam announces Wood as new finance chief

(ShareCast News) - Life science research tools firm Abcam announced on Monday the appointment of Gavin Wood as its chief financial officer. The AIM-traded firm said Wood, who is the former executive vice president and CFO of Affymetrix, is to join the company on 18 July and succeed Jeff Iliffe after

Read more
20 Jun 2016 06:40

Abcam Appoints Gavin Wood As New Chief Financial Officer

Read more
5 Apr 2016 08:32

BROKER RATINGS SUMMARY: Liberum Upgrades Babcock To Hold From Sell

Read more
14 Mar 2016 09:33

BROKER RATINGS SUMMARY: HSBC And Merrill Lynch Downgrade Admiral

Read more
10 Mar 2016 16:13

Dividends Calendar - Week Ahead

Read more
7 Mar 2016 14:30

Abcam shares sink on news of lower earnings

(ShareCast News) - Abcam tried to paint its interim results as strong on Monday, with the biotechnology company making increased investment for the future, though the market did not agree in afternoon trading. The AIM-traded firm saw revenue rise 17.2% on a constant currency basis and 18% on a repor

Read more
7 Mar 2016 07:51

Abcam Confident In Meeting Full-Year Targets As COO To Retire

Read more
29 Feb 2016 16:08

Earnings, Trading Statements Calendar - Week Ahead

Read more
26 Jan 2016 09:43

BROKER RATINGS SUMMARY: UBS Upgrades RBS To Buy From Neutral

Read more
25 Jan 2016 10:36

Avacta Poaches Abcam's Cotrel For Chief Commercial Officer Role

Read more
25 Jan 2016 07:56

Abcam Expects Revenue Growth Of 17% For First Half

Read more
5 Jan 2016 09:43

BROKER RATINGS SUMMARY: S&P CapIQ Cuts Next To Buy From Strong Buy

Read more
27 Nov 2015 15:44

Dividends Calendar - Week Ahead

Read more
11 Nov 2015 16:40

DIRECTOR DEALINGS: Abcam CEO Buys GBP19,343 Of Stock After AxioMx Deal

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.